CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

When is a Vaccine not a Vaccine?

Simple question and in theory, the answer is as simple. A vaccine is a vaccine when it conforms to the properties we assign historically...

FDA Approves Drug Combination for Treating Mesothelioma

First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...

Drug Shortages During the Time of Coronavirus

An astonishing 82% of drug shortages are listed as reason unknown. The other causes include manufacturing, discontinuation, raw materials, and supply and demand.